An Overview of Perrigo
Perrigo Company is a leading provider of over-the-counter (OTC) healthcare products and other consumer goods. It is headquartered in Ireland but has operations in over 25 countries across the world. Perrigo's main products include a range of OTC medicines, nutritional products and infant formulas. The company also produces and distributes generic versions of prescription drugs, as well as medical devices and other related products. Perrigo has been in business since 1887 and is listed on the New York Stock Exchange.
The History of Perrigo's Stock Price
Perrigo's stock price saw a massive surge in the early 2000s. From 2001 to 2005, the price rose from $11 to over $80 per share. This marked the start of an incredible bull run that saw the price reach a peak of over $200 per share in late 2007. The following year saw a significant drop in the stock price as the global financial crisis hit and the company's earnings suffered. However, the stock price began to recover in the years after the crisis and by 2012, it had returned to the $80 per share mark.
The Recent Performance of Perrigo Stock
In the past few years, Perrigo’s stock price has been on a steady upward trend. In the last five years, the stock has risen from $90 per share to over $165 per share. The company has seen consistent growth in sales and profits, largely driven by the sale of its OTC products. The company has also continued to focus on its cost-cutting initiatives, which have helped to drive its bottom line. The company's stock price has also been buoyed by the positive outlook for the healthcare sector as a whole.
What's Driving Perrigo's Stock Price?
Perrigo’s stock price has been driven by a number of factors in recent years. The company’s focus on cost-cutting initiatives has helped to drive its bottom line. In addition, the company has benefited from the growth in the healthcare sector as a whole. This has helped to drive demand for its products, which has in turn helped to push up its stock price. Additionally, the company’s acquisition of generic drugmaker Valera in 2014 has also had an impact on its share price.
Looking Ahead for Perrigo Stock
The future looks bright for Perrigo stock. The company’s focus on cost-cutting initiatives and its acquisition of Valera have given it a strong platform for growth. In addition, the growth in the healthcare sector as a whole is likely to continue to benefit the company’s stock price. As such, investors can expect the price to continue to rise in the years ahead.
Conclusion
Perrigo has seen a remarkable stock price history in the past two decades. The company has benefited from the growth in the healthcare sector as a whole, as well as its cost-cutting initiatives. In addition, its acquisition of Valera has also helped to drive its stock price. With the future looking bright for the company, investors can expect the stock price to continue to rise in the years ahead.